Trials / Completed
CompletedNCT01933646
Burden of Invasive Group B Streptococcal (GBS) Disease in Young Infants in China
Burden of Invasive Group B Streptococcal (GBS) Disease in Young Infants in China: Incidence, Case Fatality Rate and Serotype Distribution
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 10 (actual)
- Sponsor
- Novartis Vaccines · Industry
- Sex
- All
- Age
- 90 Days
- Healthy volunteers
- Not accepted
Summary
Evaluate the burden of invasive group B streptococcal (GBS) disease in young infants (up to 90 days of age) in China, in terms of incidence, case fatality rate and serotype distribution
Conditions
Timeline
- Start date
- 2013-09-01
- Primary completion
- 2014-09-01
- Completion
- 2014-09-01
- First posted
- 2013-09-02
- Last updated
- 2015-01-07
Locations
3 sites across 1 country: China
Source: ClinicalTrials.gov record NCT01933646. Inclusion in this directory is not an endorsement.